Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
25
Hundreds of millions of yenWording
Definitive
How definitive the wording is.Announced details
Corporate venture capital (CVC)
Applicable field (uses covered by this announcement)
A broad range of fields, starting with biotechnology, that contribute to resolving social issues and creating new value
Launch date13 May 2026 (activities commence and implementation begins)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Corporate venture capital (CVC) |
| Launch date | 13 May 2026 (activities commence and implementation begins) |
| Applicable area | A broad range of fields, starting with biotechnology, that contribute to resolving social issues and creating new value |
Items this document does not state (15)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To accelerate open innovation, starting with biotechnology, through investments in and collaboration with startups and venture companies possessing outstanding technologies and assets, thereby adding new value to existing businesses and contributing to the development of new businesses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.